Statins are commonly used drugs in the treatment of hypercholesterolaemia. There are many adverse effects of statins on skeletal muscle, but the underlying mechanisms remain unclear. In the present study, the effects of low dose (20 mg/kg) simvastatin, a lipophilic statin, on rat EDL muscle (extensor digitorum longus muscle) were investigated at the molecular level using FTIR (Fourier-transform infrared) spectroscopy. FTIR spectroscopy allows us rapid and sensitive determination of functional groups belonging to proteins, lipids, carbohydrates and nucleic acids simultaneously. The results revealed that simvastatin treatment induces a significant decrease in lipid, nucleic acid, protein and glycogen content. A significant increase in the lipid/protein and nucleic acid/protein ratios was also obtained with simvastatin treatment. Furthermore, an increase in lipid order and membrane fluidity was detected. A decrease in the bandwidth of the amide I band and shifting of the position of this band to higher frequency values in treated muscle indicates structural changes in proteins. Detailed secondary structure analysis of the amide I band revealed a significant increase in antiparallel and aggregated β-sheet, random coil structure and a significant decrease in β-sheet structure, which indicates protein denaturation.
INTRODUCTION
Statins, also known as HMG-CoA (hydroxy-3-methylglutarylCoA) reductase inhibitors, are the most commonly used lipidlowering drugs. They block cholesterol biosynthesis by inhibiting HMG-CoA reductase enzyme. They are widely used in the treatment of hypercholesterolaemia [1] [2] [3] . Even though statins are clinically in common use, some of their adverse effects were reported in skeletal muscle. These myotoxic effects may range from myalgia and myopathy to potentially life-threatening rhabdomyolysis [1] . The incidence of these myotoxicities is known to be dose dependent. In a previous study, the incidence of myopathy with patients receiving 20 mg of simvastatin/day was found to be 0.02 %, whereas this rate was observed to be 0.4 % in patients receiving 40 or 80 mg of simvastatin/day [4] . Moreover, the prevalence of these symptoms increases when statins are used with other drugs such as cyclosporin, fibrate and gemfibrozil. Additionally, the lipophilic or hydrophilic properties of statins also affect the incidence of these adverse effects in skeletal muscle 
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since the lipophilic statins enter the cell by simple diffusion especially in non-hepatic tissues [5] .
Little is known about the mechanisms of statin-induced skeletal-muscle injury. Statins lead to apoptosis by reducing the amount of small GTP-binding proteins [2] . They disrupt cellular respiration and energy metabolism by decreasing synthesis of ubiquinone (coenzyme Q10), an essential element of mitochondria [6] . It was also reported that statins affect membrane fluidity and its electrical properties by reducing the cholesterol content of skeletal-muscle membranes [7] .
Simvastatin is more myotoxic than pravastatin due to its lipophilicity resulting in its greater uptake by myocytes [5] . Moreover, simvastatin has the second highest incidence rate in rhabdomyolysis, which is one of the myotoxic effects of statins [8] . The number of biochemical and morphological studies on simvastatin-skeletal muscle interactions is very limited. There is agreement in the literature that the protein and nucleic acid content are decreased as a result of simvastatin treatment [5, 9] . However, there are conflicting results about the drug-induced changes in the amount of lipids [10, 11] . Despite these studies the effects of this drug on the structure and function of macromolecules in rat EDL muscle (extensor digitorum longus muscle) have not been reported before and these effects need to be clarified at the molecular level. Therefore, in the present study, we studied the effect of simvastatin on rat EDL muscle to better understand its molecular mechanism. To achieve this, we performed FTIR (Fourier-transform infrared) spectroscopy and determined simvastatin-induced alterations in the concentration, content, structure and dynamics of macromolecules, which, to the best of our knowledge, have not been reported previously.
FTIR spectroscopy is a non-destructive, rapid and sensitive technique that simultaneously monitors different functional groups belonging to macromolecules of biological tissues. Using this technique we can detect even very small variations and early alterations in disease conditions [12] . The shifts in peak positions, changes in bandwidth and area values of the bands give valuable structural and functional information on biological materials [12] [13] [14] [15] [16] .
MATERIALS AND METHODS

Materials
Simvastatin (Zocor) was purchased from Merck, Sharp and Dohme (West Point, PA, U.S.A.) as tablets, each of 40 mg. Potassium bromide (KBr) was obtained from Merck (Darmstadt, Germany). All chemicals were obtained from commercial sources at the highest grade of purity available.
Preparation of experimental animals
Adult male Wistar rats (12-14 weeks) weighing 250-300 g (Experimental Animal Center, Hacettepe University, Ankara, Turkey) were selected randomly. The rats were fed with a standard diet with water ad libitum, and kept in a conventional room with controlled light (12 h light/12 h dark), temperature (22 + − 1
• C), relative humidity (40-50 %) and ventilation (15 air changes per hour). They were allowed to adapt to their environment for 1 week prior to the experiments. All procedures used in the experiments were approved by the Ethics Committee of Hacettepe University.
The rats were separated into two groups as control (n = 10) and simvastatin-treated (n = 8). The control group received serum physiological solution. Simvastatin in serum physiological solution (20 mg/kg per day) was given to the simvastatin treatment group daily by intragastric intubations using stainless curved feeding needle (18 ga, 3 in; Stoelting) for 30 days and they were weighed weekly. At the end of the treatment period, rats were anaesthetized with diethyl ether. Blood samples were drawn to measure serum cholesterol levels by using HPLC, and EDL samples were then dissected and stored at -80
• C for experimental analysis.
Sample preparation for FTIR and HPLC studies
The EDL samples were dried overnight in a Labconco freezedrier (Labconco FreeZone ® , 6 litre Benchtop Freeze Dry System
Model 77520) to remove the free water. The dried samples were ground with liquid nitrogen in a liquid nitrogen-cooled colloid mill (Retsch MM200) to obtain tissue powder. The tissue powder was mixed with dried potassium bromide (KBr) in a mortar (in the ratio 0.5:150) and dried further in the freeze-drier for 18 h to remove all traces of the remaining free or unbound water. The mixture was compressed into a thin KBr disc under a pressure of ∼100 kg/cm 2 producing transparent discs for FTIR studies [12, 13] .
The measurement of serum cholesterol levels was performed by HPLC as reported in detail by Yilmaz et al. [17] .
FTIR spectra and data analysis
IR spectra of EDL samples were obtained using a PerkinElmer Spectrum 100 FTIR spectrometer (PerkinElmer, Norwalk, CT, U.S.A.) equipped with a MIR TGS detector. The interfering spectrum of air and KBr transparent disc was recorded as background and subtracted automatically by using appropriate software (Spectrum 100 software). The spectra were recorded in the 4000-400 cm −1 region at room temperature (21 • C). A total of 50 scans were taken for each interferogram at 4 cm −1 resolution. Collections of spectra and data manipulations were carried out using Spectrum 100 software (PerkinElmer). Each sample was scanned as three different replicates under the same conditions, all of which gave identical spectra. The average spectra of these three replicates were then used in detailed data and statistical analysis. Using the same software, the spectra were first smoothed with nine-point Savitsky-Golay smooth function to remove the noise. The average spectra were baseline-corrected and normalized with respect to specific bands for visual demonstration. During the determination of the mean values of the peak positions, band area and bandwidth, the average spectra belonging to the individuals of each group, were considered. The band positions were measured using the frequency corresponding to the centre of weight from raw spectra. The band areas were calculated from smoothed and baseline-corrected spectra using Spectrum software. The bandwidth value of amide I band was calculated as the width at 0.75× height of the absorption signal in terms of cm −1 from raw spectra. Moreover, the bandwidth of the CH 2 asymmetric stretching band was calculated from 0.75× height of both absorption and well-resolved second derivative spectra in terms of cm −1 . For the determination of simvastatin-induced protein secondary structure variations, amide I band was used and detailed analysis was carried out using the OPUSNT data collection software package (Bruker Optics, Reinstetten, Germany). Firstly, the second derivatives spectra were obtained by applying a SavitzkyGolay algorithm with nine smoothing points and these derivatives vector normalized at 1700-1600 cm −1 and then the peak intensities were calculated. The peak minima of the second derivative signals were used, since they correspond to the peak positions of the original absorption spectra [12] . Mann-Whitney U test. A P value less than or equal to 0.05 was considered as statistically significant. The degree of significance was denoted as *P < 0.05, **P < 0.01 and ***P < 0.001.
RESULTS AND DISCUSSION
The present study was carried out to determine simvastatininduced molecular variations in EDL muscle using FTIR spectroscopy. In this study, the EDL muscle was studied because it is known to be more affected by statin therapy [18] . It is well known that EDL muscle is largely composed of type II skeletalmuscle fibres (3 % type I, 57 % type IIa and 40 % type IIb) having a fast-contracting glycolytic characteristic [19] .
Simvastatin treatment led to a decrease in the weight of drug-treated animals at the end of 1 month of treatment period (P < 0.05). The initial weight of these animals was 273.33 + − 12.72 g and at the end of the treatment period they weighed 246.83 + − 12.90 g. On the other hand, the initial weight of the control animals was 258.37 + − 10.84 g and at the end of the vehicle administration period they weighed 269.87 + − 17.04 g.
Simvastatin treatment at 20 mg/kg per day for 30 days significantly lowered the plasma cholesterol levels (P < 0.05). The mean plasma cholesterol level of simvastatin-treated animals was 123.05 + − 5.89 μg/ml, whereas it was 134.56 + − 10.23 μg/ml in the control animals.
In the present study, FTIR spectroscopy of dried tissue samples was performed. This method was extensively used by our group [13, 20] and others [21, 22] to study homogeneous tissue samples. In the drying process, free and unbound water was removed from the system, whereas intra-and inter-molecular water remained in the system as can be seen in Table 1 and Figure 2 (A) [20] . Since the free water was removed from the system, it may not monitor well the properties of biological samples in the hydrated state. As we have reported previously, there can be differences in the IR spectra, especially between dissolved and freeze-dried proteins [20] . It is also well known that the physical properties of membranes vary as hydration level changes [23] . Furthermore, the removal of water from the specimens causes lyotropic mesomorphic changes in lipid phase behaviour, which certainly will cause some insignificant interpretations extrapolated to hydrated systems [24, 25] . Therefore the studies with dry biological samples are not appropriate for quantitative measurements, but instead can be used to deduce relative information. To achieve this, we were very careful to perform the experiments under identical conditions, e.g. the same amount of dehydration, equivalent temperature and pressure. In the present study, since the main point of interest was not to determine the properties of real hydrated systems, but instead to determine the relative changes between macromolecular composition and structure of two identical preparations of simvastatin-treated and untreated tissues, this may not introduce a significant problem. Table 1 . The changes in the frequency of these bands monitor structural variations; the signal intensity, or more accurately the area under the bands, gives information about the concentration of the related molecules [14, 15] . Although the normalized average spectra were presented in the Figures to visually demonstrate the comparative changes, for the accurate determination of variations in the spectral parameters, raw spectra belonging to the control and simvastatin-treated samples were considered. Baselined spectra were used only for band area determination.
The mean values and statistical analysis were performed, accordingly.
As can be seen from Figures 1 and 2(A) , the broad band located between 3600 and 3100 cm −1 mainly consists of two bands. The band located at approx. 3500-3300 cm −1 mainly arises from the N-H stretching vibrations of hydrogen-bonded amide groups of proteins (amide A) with little contribution from the O-H stretching of polysaccharides and intermolecular H-bonding (band 2) [13, 26] . The contribution of free water molecules to this band can be neglected because free or unbound water was largely removed during the preparation of the skeletal-muscle specimens. This band overlaps with the O-H stretching (intramolecular H-bonding, which was labelled as band 1) located at approx. 3450-3570 cm −1 [13, 27] . This band monitors the bound water in skeletal-muscle samples.
In the C-H stretching region, absorptions arising from the olefinic =CH, CH 2 and CH 3 stretching groups are monitored ( Figure 2B ). The olefinic band (3010 cm −1 ) arises from the C-H stretching mode of the HC=CH groups and can be used as a measure of unsaturation in the acyl chains [12, 28] . As seen from the Figure, the area of this band decreased in simvastatin-treated muscle (P < 0.05), indicating a decrease in the population of unsaturation in acyl chains of lipid molecules. This loss of unsaturation may be due to an increase in lipid peroxidation [28] . It was previously reported that after the termination of statin therapy, the level of 8-epi-PGF2a in serum, plasma and urine decreased, which is an indicator of a significant in vivo oxidation injury, supporting our result [29] . In addition, the frequency of this band shifted to higher values in simvastatin-treated EDL muscle (P < 0.01), indicating disordering of the unsaturated lipids [30] . The CH 2 antisymmetric/symmetric and CH 3 asymmetric stretching bands originate mainly from the lipid acyl chains ( Table 1) . The area of these bands decreased (P < 0.05) in simvastatintreated muscle. This suggests a reduction in the amount of lipids and a change in the composition of the acyl chains [15] . This result was also supported by the decrease in the area of the CH 2 bending mode belonging mainly to lipids, at 1452 cm −1 , COO − symmetric stretching (fatty acids) at 1392 cm −1 and in the ratio of lipid bands (CH 2 asym./CH 2 sym.). This prevalent decrease in lipid content may be due to an increase in skeletal-muscle lipolysis or utilization of lipid sources because of statin treatment. By monitoring the olefinic band, we cannot clearly distinguish whether the decrease in this band is due to a decrease in the concentration of unsaturated lipids or due to change in unsaturation. In the present study, we also obtained the ratio of saturated to unsaturated lipids by calculating the ratio of the areas of the bands Figure 2 Representative IR spectra of control and simvastatin-treated EDL muscles (A) The 3750-3025 cm −1 region; (B) the 3025-2800 cm −1 region (C-H stretching region); (C) the 1900-780 cm −1 region ('fingerprint' region). The spectra were normalized with respect to the CH 2 asymmetric stretching band (A, B) and the amide I band (C).
Table 2 Changes in the frequency and area values of the IR bands for control and simvastatin-treated EDL muscles
The values are the means + − S.D. for each group. Comparisons were done by the Mann-Whitney U-test. The downward arrow indicates a decrease and the upward arrow indicates an increase with respect to the control. The degree of significance is denoted as *P < 0.05, **P < 0.01 and ***P < 0.001. a.u., arbitrary unit. arising from saturated lipids (CH 2 asymmetric+CH 2 symmetric) and unsaturated lipids (=CH). A significant increase in this ratio (P < 0.01) from 3.06 + − 1.38 to 6.76 + − 0.65 was observed, which indicates a more pronounced decrease in the amount of unsaturated lipids in comparison with the saturated ones, since simvastatin treatment induces a decrease in the content of both types of lipids [14] . It is known that free radicals modify the lipid composition of the membranes by altering the unsaturated/saturated fatty acid ratio of membrane phospholipids. The increase in this ratio indicates that simvastatin treatment might induce lipid peroxidation in tissues due to the formation of free radicals. The shifts in the frequencies of the CH 2 stretching vibrations can be used as markers for the detection of changes in acyl chain flexibility (order/disorder state of lipids). As can be seen from Table 2 and Figure 3 , the peak positions of these bands shifted slightly but significantly to lower values (P < 0.05). This indicates an increase in the number of trans conformers of lipid molecules, i.e. an increase in lipid order [32] . One possible explanation for the observed membrane rigidity can be the simvastatin-induced domain formation since we recently reported simvastatin-induced lateral phase separation in model membranes using differential scanning calorimetry [33] . Another explanation may be free radical formation as a result of statin treatment. Free radicals modify the lipid composition of the membranes by altering the unsaturated/saturated fatty acid ratio of membrane phospholipids. This results in an increase in the rigidity of the membrane [31] . Bandwidths of the C-H bands give information about the dynamics of the system [30, 34] . The increase in the bandwidth of the CH 2 asymmetric stretching band suggests an increase in the lipid fluidity of the treated muscle (P < 0.01) [12] . We also calculated the bandwidth values of the CH 2 asymmetric stretching band from the well-resolved second derivative spectra and found similar results to those obtained from the absorption signal (Table 3) . This may be due to a decrease in the cholesterol level since membrane cholesterol concentration affects its fluidity [35] . It has also been reported that statins affect skeletal-muscle membrane fluidity through changes in cholesterol content [6, 36] . We indeed observed a dramatic decrease (P < 0.05) in the 1740 cm
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band, which is due to cholesterol esters and triacylglycerols (Figure 2C) , implying a relative decrease in the concentration of ester groups belonging to triacylglycerols and cholesterol esters [15, 37] . This was also confirmed by the decline in the area of the other cholesterol ester band, namely CO-O-C asymmetric stretching bond located at 1170 cm −1 [38] . One of the important factors affecting the membrane structure and dynamics is the amount of proteins and lipids in the membranes [14, 15] . A precise lipid-to-protein ratio can be derived from the FTIR spectrum by calculating the ratio of the areas of the bands arising from lipids (CH 2 asymmetric, CH 2 symmetric), and proteins (amide I). As seen from Table 3 , the ratio (CH 2 asym. + CH 2 sym./amide I, CH 2 asym. stretch. + CH 2 sym. stretch./CH 3 sym. stretch.) was much higher in simvastatin-treated EDL muscle (P < 0.01). The increase of this . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 3 Changes in the bandwidth values and the area ratios of some of the IR bands for control and simvastatin-treated EDL muscles
The values are the means + − S.D. for each group. Comparisons were done by the Mann-Whitney U-test. The downward arrow indicates a decrease and the upward arrow indicates an increase with respect to the control. The degree of significance is denoted as *P < 0.05 and **P < 0.01. ratio in the treated muscle suggests that there was a much more pronounced decrease in protein content when compared with those of lipid content. The bands at approx. 1657 and 1541 cm −1 can be attributed to amide I and II vibrations of structural proteins respectively [39] . As can be clearly seen in Table 2 , the significant decrease in the area values of these bands indicates a reduction in the protein content in treated muscle samples. These results were also consistent with the decrease in other protein bands, namely amide A band (at 3330 cm −1 ), amide B band (at 3062 cm −1 ), CH 3 symmetric stretching band (at 2876 cm −1 ) and in the ratio of protein bands (amide I/amide II). A possible explanation for the decrease in protein content is that statins decrease the serum levels of lipids and fatty acids and this situation forces the muscle to use amino acids from proteins as an energy source. It has been suggested that extreme protein degradation will damage the muscle if the usage of proteins by skeletal muscle continues for a long period and this may cause the formation of acute myopathy and rhabdomyolysis [40] .
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The bandwidth of amide I band decreased significantly (P < 0.01) (Table 3 ) and the frequency of the amide I and II bands shifted to higher values in simvastatin-treated EDL muscle (Table 2) , indicating conformational changes in tissue proteins [15] . It was previously reported that in more than 50 % of patients, biochemical and/or genetic abnormalities of proteins or genes that are involved in skeletal-muscle energy metabolism are associated with statin-related myopathy, supporting the changes in the synthesis and conformation of tissue proteins induced by statins [41] . The changes in the protein structure were determined from the intensities of the sub-bands in the second derivative of the amide I absorbance band where six peaks were observed ( Figure 3B ) and the intensity values of them are listed in Table 4 . The peak located at 1676 cm −1 is due to antiparallel β-sheet structure, the peak at 1680 cm −1 arises from turns and bends, the peak located at 1638 cm −1 is due to β-sheet structures, the peak at 1652 cm −1 corresponds to an α-helix structure, the peak at 1642 cm −1 is assigned to random coil structure and the peak at approx. 1625 cm −1 is attributed to aggregated β-sheet structure [42] . The results revealed that simvastatin treatment significantly decreased β-sheet structure and significantly increased random coil, antiparallel and aggregated β-sheet structure. The increase in random coil and aggregated β-sheet structures indicates simvastatin-induced protein denaturation [43, 44] .
As seen from Table 2 and Figure 2 (C), the significant decrease (P < 0.05) in the area of the band located at 1343 cm −1 , which originates from CH 2 side chain vibrations of collagen [45] , indicates a decrease in the amount of collagen in simvastatin-treated muscle. It has been previously reported that pravastatin inhibits type IV collagen secretion in fetal calf serum because of suppression of mevalonate pathway products, which play a critical role in the proliferation of mammalian cells [46] .
The asymmetric and symmetric phosphate stretching bands at 1261, 1236 and 1080 cm −1 respectively originate mainly due to the phosphodiester backbone of cellular nucleic acids and phospholipids [13, 15] . As seen from Figure 2 (C) and Table 2 , the frequencies of these bands shifted to higher values in simvastatintreated muscles (P < 0.01 at 1261 and 1080 cm −1 ). The shifts to higher values in the frequencies of these bands indicate dehydration around the PO 2 − functional groups in phospholipids and/or a change in the conformation of nucleic acids. Moreover, the areas of these bands decreased dramatically in EDL muscle (P < 0.05 at 1236 and 1080 cm −1 ). This decrease is consistent with the decrease at 976, 929 and 806 cm −1 bands, which are also due to RNA and DNA. These results imply a decrease in the relative concentration of the nucleic acids in the treated muscle, which may be due to statin-induced nuclear condensation and fragmentation through the activation of caspase 3 enzymes [47] .
The peak area ratio of the bands at 1080 cm −1 (phosphate symmetric stretching nucleic acid) and 1540 cm −1 (amide II-protein) is often used to illustrate the change in the DNA and protein content of cells [48] . A decrease in both protein and DNA content was observed in simvastatin-treated EDL muscle (Table 2) . A higher ratio value implies a more dramatic decrease in protein content when compared with the DNA content (P < 0.01) ( Table 3 ). Our result supported that statins affect the ubiquitin proteasome pathway which is tightly regulated and responsible for the recognition and degradation of most of the proteins in skeletal muscle [49] .
As seen from the Tables, the spectral values between the control and simvastatin-treated groups seem to be small, but the changes are so consistent that the S.D. values are very small and significant, which again shows the high sensitivity of the FTIR spectroscopy technique. In FTIR spectroscopy, the data obtained . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . are stored in digitally encoded formats, which facilitate spectral interpretation with the aid of post-acquisition data manipulation algorithms. This property of the technique allows the accurate detection of small changes even in the weak absorption bands [12] .
In conclusion, in the present study, by using FTIR spectroscopy, it was observed that simvastatin treatment induced significant structural, functional and compositional alterations in the rat EDL muscles. A decrease was found in the amount of protein, saturated and unsaturated lipids, cholesterol esters, triacylglycerols, glycogen and nucleic acid in simvastatin-treated EDL muscles. Simvastatin treatment also leads to a conformational change in protein and nucleic acid structure. In addition, in the present study, information on the effect of simvastatin on lipid order, fluidity and protein secondary structure was reported for the first time, in skeletal muscle. It was observed that simvastatin increased lipid order and fluidity. While the fraction of random coil, antiparallel and aggregated β-sheet structure increased, β-sheet structure decreased indicating simvastatin-induced protein denaturation. These kinds of structural, compositional and dynamical information are very important, because today a correlation of these parameters to ion channel activities has been proposed. It is known that any change in these parameters causes alterations in the function of ion channels [50] . 
